Onderzoeker
Liselore Loverix
- Disciplines:Gynaecologie, Verloskunde
Affiliaties
- Gynaecologische Oncologie (Afdeling)
Lid
Vanaf15 aug 2019 → Heden
Projecten
1 - 1 of 1
- Predictive genetic merkers voor gerichte therapie bij gynaecologische tumoren: van een standaard naar meer gepersonaliseerde behandelingsaanpak.Vanaf1 aug 2019 → HedenFinanciering: FWO Strategische Onderzoeksbeurs
Publicaties
1 - 10 van 11
- CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study(2023)
Auteurs: Diether Lambrechts, Liselore Loverix, Toon Van Gorp, Ignace Vergote
- Nucleosome footprinting in plasma cell-free DNA for the pre-surgical diagnosis of ovarian cancer(2022)
Auteurs: Pieter Busschaert, Siel Olbrecht, An Coosemans, Wouter Froyman, Liselore Loverix, Sileny Han, Toon Van Gorp, Tom Venken, Ruben Heremans, Patrick Neven, et al.
- Randomized CLIO/BGOG-ov10 trial of olaparib monotherapy versus physician's choice chemotherapy in relapsed ovarian cancer(2022)
Auteurs: Liselore Loverix, Pieter Busschaert, Els Van Nieuwenhuysen, Sileny Han, Siel Olbrecht, Patrick Neven, Diether Lambrechts, Toon Van Gorp, Ignace Vergote
Pagina's: 14 - 22 - Association of a Combined Cancer Exhaustion Score with Circulating Tumor Cells and Outcome in Ovarian Cancer-A Study of the OVCAD Consortium(2021)
Auteurs: Liselore Loverix, Toon Van Gorp, Ignace Vergote
- MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma(2021)
Auteurs: Diether Lambrechts, Liselore Loverix, Siel Olbrecht, Ignace Vergote
Pagina's: 855 - 871 - High-grade serous tubo-ovarian cancer refined with single-cell RNA sequencing: specific cell subtypes influence survival and determine molecular subtype classification(2021)
Auteurs: Siel Olbrecht, Pieter Busschaert, Jun Qian, Liselore Loverix, Toon Van Gorp, Els Van Nieuwenhuysen, Sileny Han, An Coosemans, Anne-Sophie Van Rompuy, Diether Lambrechts, et al.
- The Long-Term Prognostic Significance of Circulating Tumor Cells in Ovarian Cancer-A Study of the OVCAD Consortium(2021)
Auteurs: Liselore Loverix, Ignace Vergote
- Definition and Independent Validation of a Proteomic-Classifier in Ovarian Cancer(2020)
Auteurs: Ignace Vergote, Liselore Loverix
- miR-181a overexpression predicts the poor treatment response and early-progression of serous ovarian cancer patients(2020)
Auteurs: Ignace Vergote, Liselore Loverix
Pagina's: 3560 - 3573 - Para-aortic lymph node surgical staging in locally-advanced cervical cancer: comparison between robotic versus conventional laparoscopy(2020)
Auteurs: Liselore Loverix, Els Van Nieuwenhuysen, Sileny Han, Toon Van Gorp, Ignace Vergote
Pagina's: 466 - 472